"ROUSTRIN F 20: Advanced Lipid Control Formula"

ROUSTRIN F 20 

Rosuvastatin (20mg), Fenofibron (160mg)

Rosuvastatin (20mg): Superior Cholesterol Reduction

ROUSTRIN F 20 features Rosuvastatin at a 20mg dose, which provides a robust approach to lowering cholesterol. This higher dosage is particularly effective for patients with severe hypercholesterolemia or those at high risk for cardiovascular events. Rosuvastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver, thus lowering the levels of LDL cholesterol and increasing HDL cholesterol.

Fenofibrate (160mg): Triglyceride and Lipid Management

Fenofibrate at 160mg within ROUSTRIN F 20 targets high triglycerides, a common issue in patients with metabolic syndrome. It operates by activating peroxisome proliferator-activated receptors (PPARs), which enhance the oxidation of fatty acids and improve lipid profiles. This not only helps in reducing triglyceride levels but also aids in the management of total cholesterol and LDL cholesterol.

The Combined Impact of Rosuvastatin and Fenofibrate

The dual mechanism of ROUSTRIN F 20, combining Rosuvastatin and Fenofibrate, offers a comprehensive solution for managing complex lipid disorders. This combination is particularly beneficial for patients who have not achieved their lipid goals with single-agent therapy, providing a potent approach to prevent cardiovascular diseases.

Ideal Candidates for ROUSTRIN F 20

ROUSTRIN F 20 is ideal for patients with mixed dyslipidemia, particularly those who are at a higher risk for cardiovascular complications. It is also suitable for patients who have genetic factors that contribute to high cholesterol and triglycerides, requiring more intensive treatment to manage their lipid levels effectively.

Conclusion

ROUSTRIN F 20 stands out as a powerful medication in the landscape of lipid management, offering significant benefits in reducing cholesterol and triglycerides. By using a combined approach, it provides a strategic option for patients needing aggressive treatment for their lipid disorders.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW